Clover Health Investments Corp
NASDAQ:CLOV
Clover Health Investments Corp
NASDAQ:CLOV
Kurs:
3,98
USD
-4,78%
Markt geschlossen
Marktkap.:
$2,09 Mrd.
Notiz hinzufügen
Kursziel hinzufügen
Gedanken festhalten und ein Kursziel setzen
Legen Sie fest, zu welchem Kurs Sie kaufen würden. Wir helfen Ihnen, bereit zu bleiben.
Basierend auf
Sicherheitsmarge
0%
10%
20%
30%
40%
50%
Ihr Kursziel
Verknüpft mit
aktuellem Kurs
· In Kaufzone
Lädt
Notiz verknüpft
Wählen Sie die Aktie, die Sie mit einem Kursziel beobachten möchten
Zuletzt angesehen
|
Clover Health Investments Corp
NASDAQ:CLOV
|
US |
|
C
|
China Petroleum & Chemical Corp
SWB:CHU
|
CN |
|
S
|
SoftBank Corp
F:3AG0
|
JP |
|
U-Haul Holding Co
NYSE:UHAL
|
US |
|
Radian Group Inc
NYSE:RDN
|
US |
|
C
|
Canadian National Railway Co
SWB:CY2
|
CA |
|
ITV PLC
LSE:ITV
|
UK |
|
O
|
Osaka Gas Co Ltd
DUS:OSA
|
JP |
|
G
|
GameStop Corp
F:GS2C
|
US |
|
Otis Worldwide Corp
NYSE:OTIS
|
US |
|
Pidilite Industries Ltd
NSE:PIDILITIND
|
IN |
|
M
|
Medtronic PLC
SWB:2M6
|
IE |
|
H
|
Heineken Holding NV
XMUN:4H5
|
NL |
|
V
|
Vericel Corp
XBER:ATQP
|
US |
|
C
|
Canadian Imperial Bank of Commerce
F:CAI
|
CA |
Gewinn- und Verlustrechnung
Ergebnis-Wasserfall
Clover Health Investments Corp
Clover Health Investments Corp
Gewinn- und Verlustrechnung
Clover Health Investments Corp
Clover Health Investments Corp
Währung: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatz | ||||||||||||||||||||||
| Zinsaufwand |
0
|
1
|
2
|
3
|
3
|
2
|
2
|
2
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Umsatz |
0
N/A
|
200
N/A
|
613
+206%
|
1.040
+70%
|
1.472
+42%
|
2.146
+46%
|
2.580
+20%
|
3.010
+17%
|
3.477
+16%
|
3.130
-10%
|
2.797
-11%
|
2.422
-13%
|
1.261
-48%
|
1.853
+47%
|
1.696
-8%
|
1.544
-9%
|
1.371
-11%
|
1.487
+8%
|
1.608
+8%
|
1.774
+10%
|
1.924
+8%
|
|
| Operatives Ergebnis | ||||||||||||||||||||||
| Operative Kosten |
(7)
|
(326)
|
(920)
|
(1.495)
|
(2.109)
|
(2.751)
|
(3.107)
|
(3.461)
|
(3.848)
|
(3.463)
|
(3.075)
|
(2.666)
|
(1.440)
|
(1.987)
|
(1.798)
|
(1.616)
|
(1.417)
|
(1.511)
|
(1.650)
|
(1.831)
|
(2.010)
|
|
| Vertriebs-, Verwaltungs- und Gemeinkosten |
0
|
(105)
|
(212)
|
(332)
|
(446)
|
(468)
|
(478)
|
(477)
|
(487)
|
(489)
|
(477)
|
(461)
|
(440)
|
(421)
|
(416)
|
(404)
|
(409)
|
(415)
|
(424)
|
(432)
|
(440)
|
|
| Abschreibungen |
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(2)
|
(3)
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
|
| Sonstige operative Kosten |
(7)
|
(221)
|
(708)
|
(1.163)
|
(1.662)
|
(2.282)
|
(2.627)
|
(2.981)
|
(3.360)
|
(2.972)
|
(2.596)
|
(2.204)
|
(997)
|
(1.564)
|
(1.380)
|
(1.210)
|
(1.006)
|
(1.094)
|
(1.224)
|
(1.398)
|
(1.568)
|
|
| Operatives Ergebnis |
(7)
N/A
|
(126)
-1.725%
|
(308)
-144%
|
(455)
-48%
|
(637)
-40%
|
(606)
+5%
|
(526)
+13%
|
(451)
+14%
|
(371)
+18%
|
(333)
+10%
|
(278)
+17%
|
(244)
+12%
|
(180)
+26%
|
(134)
+25%
|
(103)
+24%
|
(72)
+30%
|
(45)
+37%
|
(24)
+47%
|
(42)
-76%
|
(57)
-36%
|
(86)
-50%
|
|
| Ergebnis vor Steuern | ||||||||||||||||||||||
| Zinserträge/-aufwendungen |
0
|
84
|
(51)
|
63
|
63
|
(9)
|
125
|
9
|
9
|
(3)
|
(2)
|
(0)
|
(5)
|
(5)
|
(5)
|
(5)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Nicht wiederkehrende Posten |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
23
|
0
|
19
|
17
|
(26)
|
(24)
|
(20)
|
(18)
|
(0)
|
0
|
1
|
0
|
0
|
|
| Sonstige Erträge gesamt |
0
|
(14)
|
(14)
|
(14)
|
(14)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
|
| Vorsteuergewinn |
(7)
N/A
|
(55)
-724%
|
(373)
-575%
|
(405)
-9%
|
(588)
-45%
|
(615)
-5%
|
(402)
+35%
|
(442)
-10%
|
(339)
+23%
|
(336)
+1%
|
(261)
+22%
|
(227)
+13%
|
(210)
+7%
|
(164)
+22%
|
(128)
+22%
|
(95)
+26%
|
(46)
+51%
|
(24)
+48%
|
(42)
-74%
|
(57)
-37%
|
(86)
-49%
|
|
| Nettogewinn | ||||||||||||||||||||||
| Ergebnis aus fortgeführten Geschäftsbereichen |
(7)
|
(55)
|
(373)
|
(405)
|
(588)
|
(615)
|
(402)
|
(442)
|
(339)
|
(336)
|
(261)
|
(227)
|
(210)
|
(164)
|
(128)
|
(95)
|
(46)
|
(24)
|
(42)
|
(57)
|
(86)
|
|
| Nettogewinn |
(7)
N/A
|
(55)
-724%
|
(373)
-575%
|
(405)
-9%
|
(588)
-45%
|
(615)
-5%
|
(402)
+35%
|
(442)
-10%
|
(339)
+23%
|
(336)
+1%
|
(261)
+22%
|
(227)
+13%
|
(213)
+6%
|
(160)
+25%
|
(124)
+23%
|
(91)
+26%
|
(43)
+53%
|
(25)
+42%
|
(43)
-72%
|
(58)
-35%
|
(86)
-47%
|
|
| Verwässertes EPS |
-0,07
N/A
|
-0,14
-100%
|
-0,91
-550%
|
-0,97
-7%
|
-1,42
-46%
|
-1,29
+9%
|
-0,84
+35%
|
-0,92
-10%
|
-0,71
+23%
|
-0,71
N/A
|
-0,55
+23%
|
-0,48
+13%
|
-0,44
+8%
|
-0,34
+23%
|
-0,24
+29%
|
-0,2
+17%
|
-0,09
+55%
|
-0,05
+44%
|
-0,08
-60%
|
-0,11
-38%
|
-0,17
-55%
|
|
Wechseln zu:
Wechseln zu:
Auch interessant
Other Clover Health Investments Corp listings:
Mehr entdecken
